Literature DB >> 28061952

Anti-mycobacterial function of macrophages is impaired in a diet induced model of type 2 diabetes.

Md Abdul Alim1, Suchandan Sikder2, Tahnee L Bridson3, Catherine M Rush4, Brenda L Govan5, Natkunam Ketheesan6.   

Abstract

Type 2 diabetes (T2D) is one of the major risk factors for tuberculosis (TB). In this study, a diet induced murine model of T2D (DIMT2D) was developed and characterized in the context of metabolic, biochemical and histopathological features following diet intervention. Mycobacterial susceptibility was investigated using Mycobacterium fortuitum as a surrogate. Phagocytic capability of alveolar macrophages and resident peritoneal macrophages were determined by in vitro assays using mycolic acid coated beads and M. fortuitum. Results demonstrated that bacillary loads were significantly higher in liver, spleen, and lungs of diabetic mice compared to controls. Higher inflammatory lesions and impaired cytokine kinetics (TNF-α, MCP-1, IL-12, IFN-γ) were also observed in diabetic mice. Macrophages isolated from diabetic mice had lower uptake of mycolic acid coated beads, reduced bacterial internalization and killing and altered cytokine responses (TNF-α, IL-6, MCP-1). This model will be useful to further investigate different facets of host-pathogen interactions in TB-T2D.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Macrophage; Murine model; Phagocytosis; Tuberculosis; Type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 28061952     DOI: 10.1016/j.tube.2016.12.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  11 in total

1.  Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection.

Authors:  Kirsten A Kulcsar; Christopher M Coleman; Sarah E Beck; Matthew B Frieman
Journal:  JCI Insight       Date:  2019-10-17

2.  BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.

Authors:  Cristian Alfredo Segura-Cerda; Brenda Marquina-Castillo; Vasti Lozano-Ordaz; Dulce Mata-Espinosa; Jorge Alberto Barrios-Payán; Manuel O López-Torres; Michel de Jesús Aceves-Sánchez; Helle Bielefeldt-Ohmann; Rogelio Hernández-Pando; Mario Alberto Flores-Valdez
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

3.  Friends and foes of tuberculosis: modulation of protective immunity.

Authors:  S Brighenti; S A Joosten
Journal:  J Intern Med       Date:  2018-05-27       Impact factor: 8.989

Review 4.  Influence of diabetes mellitus on immunity to human tuberculosis.

Authors:  Pavan Kumar Nathella; Subash Babu
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

Review 5.  Cellular Immunity of Patients with Tuberculosis Combined with Diabetes.

Authors:  Peng Cheng; Liang Wang; Wenping Gong
Journal:  J Immunol Res       Date:  2022-06-01       Impact factor: 4.493

6.  Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.

Authors:  Harindra D Sathkumara; Visai Muruganandah; Martha M Cooper; Matt A Field; Md Abdul Alim; Roland Brosch; Natkunam Ketheesan; Brenda Govan; Catherine M Rush; Lars Henning; Andreas Kupz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-10       Impact factor: 11.205

Review 7.  Non-tuberculous mycobacteria immunopathogenesis: Closer than they appear. a prime of innate immunity trade-off and NTM ways into virulence.

Authors:  Marisa Cruz-Aguilar; Antonia I Castillo-Rodal; René Arredondo-Hernández; Yolanda López-Vidal
Journal:  Scand J Immunol       Date:  2021-06-22       Impact factor: 3.889

8.  Hyperglycemia and dyslipidemia: Reduced HLA-DR expression in monocyte subpopulations from diabetes patients.

Authors:  Blanca I Restrepo; Marcel Twahirwa; Chinnaswamy Jagannath
Journal:  Hum Immunol       Date:  2020-12-08       Impact factor: 2.211

9.  Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis.

Authors:  Nallely Lopez-Lopez; Ana Gabriela Ramos Martinez; Mariana Haydee Garcia-Hernandez; Rogelio Hernandez-Pando; Julio Enrique Castañeda-Delgado; Geanncarlo Lugo-Villarino; Céline Cougoule; Olivier Neyrolles; Bruno Rivas-Santiago; Monica Alejandra Valtierra-Alvarado; Marisela Rubio-Caceres; Jose Antonio Enciso-Moreno; Carmen Judith Serrano
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02-19       Impact factor: 2.743

10.  BCG and BCGΔBCG1419c protect type 2 diabetic mice against tuberculosis via different participation of T and B lymphocytes, dendritic cells and pro-inflammatory cytokines.

Authors:  Cristian Alfredo Segura-Cerda; Brenda Marquina-Castillo; Vasti Lozano-Ordaz; Dulce Mata-Espinosa; Jorge Alberto Barrios-Payán; Manuel O López-Torres; Michel de Jesús Aceves-Sánchez; Helle Bielefeldt-Ohmann; Rogelio Hernández-Pando; Mario Alberto Flores-Valdez
Journal:  NPJ Vaccines       Date:  2020-03-12       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.